|
1
|
Corina M, Vulpoi C and Brănişteanu D:
Relationship between bone mineral density, weight, and estrogen
levels in pre and postmenopausal women. Rev Med Chir Soc Med Nat
lasi. 116:946–950. 2012.
|
|
2
|
Han KO, Moon IG, Kang YS, et al:
Nonassociation of estrogen receptor genotypes with bone mineral
density and estrogen responsiveness to hormone replacement therapy
in Korean postmenopausal women. J Clin Endocrinol Metab.
82:991–995. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Turner C: Hormone replacement therapy: its
use in the management of acute menopausal symptoms. J Am Acad Nurse
Pract. 6:318–320. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Palacios S, Christiansen C, Sánchez
Borrego R, et al: Recommendations on the management of fragility
fracture risk in women younger than 70 years. Gynecol Endocrinol.
28:770–786. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lees B and Stevenson JC: The prevention of
osteoporosis using sequential low-dose hormone replacement therapy
with estradiol-17 beta and dydrogesterone. Osteoporos Int.
12:251–258. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kaya C, Dinçer Cengiz S, Cengiz B and
Akgün G: The long-term effects of low-dose 17beta-estradiol and
dydrogesterone hormone replacement therapy on 24 h ambulatory blood
pressure in hypertensive postmenopausal women: a 1-year randomized,
prospective study. Climacteric. 9:437–445. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Popp AW, Bodmer C, Senn C, et al:
Prevention of postmenopausal bone loss with long-cycle hormone
replacement therapy. Maturitas. 53:191–200. 2006. View Article : Google Scholar
|
|
8
|
Pike MC and Ross RK: Progestins and
menopause: epidemiological studies of risks of endometrial and
breast cancer. Steroids. 65:659–664. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Boué SM, Wiese TE, Nehls S, et al:
Evaluation of the estrogenic effects of legume extracts containing
phytoestrogens. J Agric Food Chem. 51:2193–2199. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen L and Lu ZP: Randomized controlled
trial of integrated traditional Chinese and western medicine
treatment for posthepatitic cirrhotic ascites: a systematic review.
Chin J Hepatol. 19:205–209. 2011.In Chinese.
|
|
11
|
Lagari VS and Levis S: Phytoestrogens in
the prevention of postmenopausal bone loss. J Clin Densitom.
16:445–449. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen Z, Lin SY, Zhou YH, et al: Analysis
of clinical features of traditional Chinese medicine symptoms and
syndromes of 220 patients with chronic aplastic anemia. Chin J
Integr Tradit West Med. 34:43–45. 2014.In Chinese.
|
|
13
|
Boué SM, Burow ME, Wiese TE, et al:
Estrogenic and anti-estrogenic activities of phytoalexins from red
kidney bean (Phaseolus vulgaris L.). J Agric Food Chem. 59:112–120.
2011. View Article : Google Scholar
|
|
14
|
Wang Y, Wang WL, Xie WL, Li LZ, Sun J, Sun
WJ and Gong HY: Puerarin stimulates proliferation and
differentiation and protects against cell death in human
osteoblastic MG-63 cells via ER-dependent MEK/ERK and PI3K/Akt
activation. Phytomedicine. 20:787–796. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Armour KJ, Armour KE, van’t Hof RJ, Reid
DM, Wei XQ, Liew FY and Ralston SH: Activation of the inducible
nitric oxide synthase pathway contributes to inflammation-induced
osteoporosis by suppressing bone formation and causing osteoblast
apoptosis. Arthritis Rheum. 44:2790–2796. 2001. View Article : Google Scholar
|
|
16
|
Samuels A, Perry MJ, Gibson RL, Colley S
and Tobias JH: Role of endothelial nitric oxide synthase in
estrogen-induced osteogenesis. Bone. 29:24–29. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang DH, Hu YS, Du JJ, et al: Ghrelin
stimulates proliferation of human osteoblastic TE85 cells via
NO/cGMP signaling pathway. Endocrine. 35:112–117. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
El-Mowafy AM, Alkhalaf M and Jaffal SM:
Nongenomic activation of the GC-A enzyme by resveratrol and
estradiol downstream from membrane estrogen receptors in human
coronary arterial cells. Nutr Metab Cardiovasc Dis. 17:508–516.
2007. View Article : Google Scholar
|
|
19
|
Pan W, Quarles LD, Song LH, et al:
Genistein stimulates the osteoblastic differentiation via NO/cGMP
in bone marrow culture. J Cell Biochem. 94:307–316. 2005.
View Article : Google Scholar
|
|
20
|
Andelman F, Kipervasser S, Maimon S, Fried
I, Parmet Y and Neufeld MY: A revised intracarotid etomidate memory
(Wada) procedure. Acta Neurol Scand. 127:97–102. 2013. View Article : Google Scholar
|
|
21
|
Hokazono E, Osawa S, Nakano T, et al:
Development of a new measurement method for serum calcium with
chlorophosphonazo-III. Ann Clin Biochem. 46:296–301. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Holzer G, Einhorn TA and Majeska RJ:
Estrogen regulation of growth and alkaline phosphatase expression
by cultured human bone marrow stromal cells. J Orthop Res.
20:281–288. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Almeida M, Martin-Millan M, Ambrogini E,
et al: Estrogens attenuate oxidative stress and the differentiation
and apoptosis of osteoblasts by DNA-binding-independent actions of
the ERalpha. J Bone Miner Res. 25:769–781. 2010.
|
|
24
|
MacIntyre I, Zaidi M, Alam AS, Datta HK,
Moonga BS, Lidbury PS, Hecker M and Vane JR: Osteoclast inhibition:
an action of nitric oxide not mediated by cyclic GMP. Proc Natl
Acad Sci USA. 88:2936–2940. 1991. View Article : Google Scholar
|
|
25
|
Galea GL, Meakin LB, Sugiyama T, et al:
Estrogen receptor α mediates proliferation of osteoblastic cells
stimulated by estrogen and mechanical strain, but their acute
down-regulation of the Wnt antagonist Sost is mediated by estrogen
receptor β. J Biol Chem. 288:9035–9048. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Turner RT, Evans GL and WakIey GK:
Mechanism of action of estrogen on cancellous bone balance in
tibiae of ovariectomized growing rat: Inhibition of indices of
formation and resorption. J Bone Miner Res. 8:359–366. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang Q, Sun L, Zhang F, et al: Effects of
17β-estradiol on cell proliferation, cAMP and cGMP content and iNOS
activity in human osteoblast-like osteosarcoma cell line TE85. Chin
Pharmacol Bull. 14:314–317. 1998.
|
|
28
|
Cervellati C, Bonaccorsi G, Cremonini E,
et al: Oxidative stress and bone resorption interplay as a possible
trigger for postmenopausal osteoporosis. Biomed Res Int.
2014:563–569. 2014. View Article : Google Scholar
|
|
29
|
Manolagas SC, O’Brien CA and Almeida M:
The role of estrogen and androgen receptors in bone health and
disease. Nat Rev Endocrinol. 9:699–712. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Michihara S, Tanaka T, Uzawa Y, Moriyama T
and Kawamura Y: Puerarin exerted anti-osteoporotic action
independent of estrogen receptor-mediated pathway. J Nutr Sci
Vitaminol (Tokyo). 58:202–209. 2012. View Article : Google Scholar
|
|
31
|
Saha P, Saraswat G, Chakraborty P,
Banerjee S, Pal BC and Kabir SN: Puerarin, a selective oestrogen
receptor modulator, disrupts pregnancy in rats at pre-implantation
stage. Reproduction. 144:633–645. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Deng Y, Ng ES, Yeung JH, et al: Mechanisms
of the cerebral vasodilator actions of isoflavonoids of Gegen on
rat isolated basilar artery. J Ethnopharmacol. 139:294–304. 2012.
View Article : Google Scholar
|
|
33
|
Sheu SY, Tsai CC, Sun JS, Chen MH, Liu MH
and Sun MG: Stimulatory effect of puerarin on bone formation
through co-activation of nitric oxide and bone morphogenetic
protein-2/mitogen-activated protein kinases pathways in mice. Chin
Med J (Engl). 125:3646–3653. 2012.
|
|
34
|
Brown JP, Dempster DW, Ding B, Dent-Acosta
R, San Martin J, Grauer A, Wagman RB and Zanchetta J: Bone
remodeling in postmenopausal women who discontinued denosumab
treatment: off-treatment biopsy study. J Bone Miner Res.
26:2737–2744. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rangaswami HI, Marathe N, Zhuang S, et al:
Type II cGMP-dependent protein kinase mediates osteoblast
mechano-transduction. Handb Exp Pharmacol. 191:137–162. 2009.
|
|
36
|
Pfeifer A, Aszódi A, Seidler U, Ruth P,
Hofmann F and Fässler R: Intestinal secretory defects and dwarfism
in mice lacking cGMP-dependent protein kinase II. Science.
274:2082–2086. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wimalawansa SJ: Rationale for using nitric
oxide donor therapy for prevention of bone loss and treatment of
osteoporosis in humans. Ann NY Acad Sci. 1117:283–297. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yang F, Zhang R, He F, Wang XX, Zhao S and
Yang G: Osteoblast response to puerarin-loaded porous titanium
surfaces: an in vitro study. J Biomed Mater Res A. 100:1419–1426.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang N, Wang X, Cheng W, et al: Puerarin
promotes osteogenesis and inhibits adipogenesis in vitro. Chin Med.
8:172013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Brown JP, Delmas PD, Malaval L, Edouard C,
Chapuy MC and Meunier PJ: Serum bone Gla-protein: a specific marker
for bone formation in postmenopausal osteoporosis. Lancet.
1:1091–1093. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Minisola S, Rosso R, Romagnoli E, et al:
Serum osteocalcin and bone mineral density at various skeletal
sites: a study performed with three different assays. J Lab Clin
Med. 129:422–429. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Koo KT, Lee SW, Lee MH, Kim KH, Jung SH
and Kang YG: Time-dependent expression of osteoblast marker genes
in human primary cells cultured on microgrooved titanium substrata.
Clin Oral Implants Res. 25:714–722. 2014. View Article : Google Scholar
|
